SEC 8-K and 6-K filings classified by Claude with reasoning, plus Form 4 insider transactions. Ingested from EDGAR’s filing stream in near-real time, reconciled overnight.
Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
Anthony Leo resigned from the Boards of Directors of BayFirst Financial Corp. and its subsidiary effective August 26, 2026. As a prior Chief Executive Officer and current director, his departure from the board is a material executive departure. The filing centers on the resignation action itself, making exec_departure the appropriate classification.
View raw filing on EDGAR →Two directors—J. Kristofer Galashan (Class II) and Paul Hackwell (Class III)—resigned from the Board effective August 26, 2026. The disclosure centers on the departure of these board members, making exec_departure the appropriate classification. Board resignations are material to investors as they affect governance and board composition.
View raw filing on EDGAR →The filing announces the passing of George Joseph, Mercury's founder and longtime chairman who led the company for over six decades. While the disclosure also mentions Gabriel Tirador's appointment as Chairman, the principal event disclosed is Joseph's death and departure from the company. The press release centers on honoring Joseph's legacy and the continuity of leadership, making the departure the salient event, though the appointment of Tirador as his successor is a secondary governance action.
View raw filing on EDGAR →William Shaver, Chief Operating Officer and Board member of McEwen Inc., retired from both positions effective immediately on August 24, 2026, after 4 years with the company and 55+ years in the mining industry. The filing also discloses three promotions within the leadership team to address operations, development projects, and permitting.
View raw filing on EDGAR →Sarah Romano's departure as Chief Financial Officer effective August 21, 2026 is the principal disclosed action. The filing explicitly states she is "no longer serving" in that role and clarifies the departure was not due to disagreement on financial reporting or controls. This is a material executive departure affecting the registrant's senior financial leadership.
View raw filing on EDGAR →Paul Cappuccio resigned from the Board of Directors on August 21, 2026, to focus on his new role as Chief Legal Officer at Reddit, Inc. This is a clear departure of a director from the registrant. While the filing notes the resignation was not due to disagreement, the material fact is the loss of a board member and the reduction of board size from six to five directors.
View raw filing on EDGAR →William Graves resigned from the Board of Directors and all four committees (Compensation, Audit, Executive, and Nominating) effective August 26, 2026. The filing explicitly states the resignation was not due to disagreement with the Company and notes forfeiture of unvested restricted stock. This is a clear executive departure—the principal disclosed action is a director leaving his positions.
View raw filing on EDGAR →Carlos Gonzalez resigned as a director of Laser Photonics Corporation effective August 20, 2026, and served on three board committees (Compensation, Nominating and Corporate Governance, and Audit). The filing discloses a director departure under Item 5.02, with explicit statement that the resignation occurred without disagreement regarding operations, policies, or practices. Director departures are material governance events affecting board composition and committee oversight.
View raw filing on EDGAR →Aris Bolisay, Renesas's representative on Wolfspeed's Board of Directors, is resigning effective September 27, 2026. While the disclosure also mentions Renesas's appointment of a Board observer and retention of re-designation rights, the principal disclosed action is the departure of a director. The filing emphasizes the resignation and explicitly states the departure is not due to disagreement, suggesting a routine transition within a shareholder agreement framework.
View raw filing on EDGAR →Kaushik Goswami notified the Delegated Sponsor of his intention to resign from his position as a director of Morgan Stanley Investment Management Inc., the delegated sponsor of the trust, effective August 19, 2026. This is a clear departure of a director from a key governance role at the entity managing the registrant, and would be material to investors in the trust.
View raw filing on EDGAR →Brandon Torres Declet, the Company's Chief Executive Officer and Chairman, resigned effective immediately on August 19, 2026, following an internal investigation that identified approximately $286,000 in personal expenses improperly recorded as business expenses. While the filing also discloses the appointment of Benjamin Williams as Interim CEO and Gregory McNeal as Non-Executive Chairman, the central disclosed event is the departure of the CEO and Chairman under circumstances involving financial misconduct, which is material to investors' assessment of the registrant's governance and financial integrity.
View raw filing on EDGAR →Stephan Toutain was terminated without cause from his position as Chief Operating Officer on August 21, 2026, triggering severance benefit obligations.
View raw filing on EDGAR →Jed Milstein, Senior Vice President & Chief Human Resources Officer, ended his employment with the Company effective August 19, 2026. While the filing also discloses that Wendy Reynolds-Dobbs assumed the interim CHRO role, the principal disclosed action is Milstein's departure. The severance arrangement references a 2017 agreement and discretionary determination by the Compensation Committee, indicating a termination without cause. This is a material executive departure affecting the registrant's leadership structure.
View raw filing on EDGAR →Kwaku Temeng, a director and Chairman of the Nominating Committee, resigned effective October 1, 2026, due to disagreement with the Board regarding strategic direction and governance practices, specifically succession planning and research priorities. This is a clear director departure triggered by substantive governance disagreement, material to investors assessing board stability and strategic alignment.
View raw filing on EDGAR →Mr. Ziqian Guan, a director of Scage Future, resigned from his position effective August 21, 2026, due to personal reasons with no disagreement with the Company. Director departures are material governance events that affect the composition and oversight structure of the board, and would be relevant to a reasonable investor's assessment of the registrant.
View raw filing on EDGAR →James L. Cunniff, President and Chief Executive Officer of Electromed, Inc., has notified the Company of his intention to retire effective on or about April 2, 2027, and is expected to resign from the Board upon retirement. The Board has engaged an executive search firm to identify a successor.
View raw filing on EDGAR →Cecilia Lenk resigned from the Board of Directors and her position as Chief Executive Officer of Netcapital Advisors Inc. (a wholly owned subsidiary) effective immediately on August 19, 2026, following court approval of her SEC settlement. The departure of a CEO is a material executive departure that would affect a reasonable investor's assessment of the registrant's leadership and governance.
View raw filing on EDGAR →Donnie Upshaw, Senior Vice President and Chief Brand and People Officer, notified the Company on August 24, 2026 of his resignation effective September 10, 2026. The disclosure centers on the departure of a named executive officer from his positions, with no indication of a replacement appointment or compensatory arrangement being the principal focus. The filing explicitly states the departure is not due to disagreement, confirming it is a straightforward resignation.
View raw filing on EDGAR →Zachary C. Parker resigned as President and Chief Executive Officer effective June 30, 2026, which is the principal disclosed action. While the filing also details compensatory arrangements (separation, advisory, and consulting agreements), the core event is the departure of the CEO. The departure of a chief executive officer is material to investors' assessment of the registrant's leadership and continuity.
View raw filing on EDGAR →Oren Attiya resigned as Chief Financial Officer effective August 23, 2026, relinquishing his roles as principal financial officer and principal accounting officer. Haggai Ravid was appointed as Interim CFO. The resignation of a CFO is material to investors as it affects financial reporting oversight and leadership continuity.
View raw filing on EDGAR →Kitty Payne, Chief Financial Officer of USBC, Inc., notified the Company on August 21, 2026 of her intention to transition from her CFO role effective August 31, 2026 to become CFO of Vast Bank, a subsidiary.
View raw filing on EDGAR →Two board members—Krishna Gupta (Class I) and Michael Davin (Class III)—resigned from the Board on August 17 and August 19, 2026, respectively. Michael Davin also held the position of Chairman of the Compensation Committee. The Board subsequently voted to reduce its size from five to three members in connection with these departures. This represents a material reduction in board composition and governance structure.
View raw filing on EDGAR →Mr. LIU Shihao resigned as an executive director of the Company effective August 22, 2026, though he continues as Chief Financial Officer. The principal disclosed action is a person leaving a director role. While the resignation was not due to disagreement and the CFO role continues, the departure from the board constitutes a material change in executive leadership and board composition that would affect a reasonable investor's assessment of governance and management structure.
View raw filing on EDGAR →Erik Strandberg, Chief Commercial Officer, is departing EBR Systems in the coming months. The CEO will assume his responsibilities during the search for a successor.
View raw filing on EDGAR →The filing discloses the resignation of two directors, Michael Howe and Donald Hunter, effective August 31, 2026, under Item 5.02(b). Both directors held significant governance roles: Mr. Hunter chaired the Audit Committee and Mr. Howe chaired the Compensation Committee. The company explicitly states the resignations were not due to disagreement, but the simultaneous departure of two senior board members with key committee leadership roles is material to investors' assessment of governance and board composition.
View raw filing on EDGAR →Mr. Dharmendra Kumar Sinha, President of Public Cloud, is departing effective September 14, 2026. The disclosure centers on the departure itself—the principal action is a named executive leaving his position. While a separation agreement is mentioned, the core event is the departure, not compensation arrangements. This is material as it involves a senior officer departure at a public company.
View raw filing on EDGAR →Jim McGinty resigned from the Board of Directors of BARK, Inc., effective August 21, 2026. The disclosure centers on the departure of a director and the resulting reduction in board size from eight to seven members. While the filing notes no disagreement with management or policies, the resignation of a board member is a material governance event affecting the composition of the company's leadership structure.
View raw filing on EDGAR →Sandra A. Van Trease resigned from the Boards of Directors of Enterprise Financial Services Corp and its subsidiary effective August 19, 2026. She held significant governance roles including chairperson of the Nominating and Governance Committee and membership on multiple board committees. Director departures are material events affecting board composition and governance structure.
View raw filing on EDGAR →The filing discloses the resignation of Brandon Torres Declet as Chief Executive Officer and Chairman of the Board, effective August 19, 2026. While the Item 7.01 disclosure also announces the appointment of Benjamin Williams as Interim CEO and Gregory McNeal as Chairman, the primary event triggering the 8-K is the departure of the sitting CEO and Chairman. The departure of a CEO is material to investors and represents the principal disclosed action, even though a successor appointment accompanies it.
View raw filing on EDGAR →Charles Swanton resigned as a Class II director of the Board effective immediately on August 18, 2026. The disclosure centers on the departure of a director from the Company's Board and its committees, with no appointment or compensation arrangement being the principal action. The resignation is material as it affects the composition of the Board and its governance structure.
View raw filing on EDGAR →The 6-K discloses that Duncan Russell, Chief Financial Officer of Aegon Ltd, will step down and leave the company in April 2027. This is a departure of a named executive officer at a major financial services holding company. The announcement explicitly states the CFO "will step down as Chief Financial Officer and leave the company," making this a clear executive departure event material to investors assessing leadership continuity and financial stewardship.
View raw filing on EDGAR →Allison Spector resigned from the Company's Board of Directors effective August 18, 2026, following a decrease in ownership by the ORCP Stockholders. The disclosure explicitly states the resignation and its effective date, and notes the Board size reduction to ten directors. While the resignation is contractually triggered by ownership changes rather than a disagreement, it remains a material director departure requiring disclosure under Item 5.02.
View raw filing on EDGAR →Mr. Maurício Augusto Silveira de Medeiros resigned from his position as a member of Embraer's Board of Directors, effective September 1, 2026. The notice explicitly states his resignation and that an alternate board member will assume the vacant position. Board-level departures are material governance events affecting the registrant's leadership structure.
View raw filing on EDGAR →James E. Galeese, Executive Vice President and Chief Financial Officer, notified the Board on August 19, 2026 of his planned retirement effective August 31, 2027. The filing discloses a departure of a named executive officer in a critical financial leadership role after more than a decade of service. While the company is conducting an orderly succession search and Galeese will remain in role for approximately one year, the principal disclosed action is the departure of the CFO, making this an exec_departure event that is material to investors assessing the company's financial leadership continuity.
View raw filing on EDGAR →Charles Travis Naugle resigned as a director and Co-Chairman of Lion Copper & Gold Corp. on August 18, 2026. Naugle had played a key role in securing US$58.5 million in funding from Rio Tinto's Nuton LLC and advancing the Yerington Copper Project to feasibility and permitting stages.
View raw filing on EDGAR →Lars Boesgaard resigned as Chief Financial Officer, Principal Financial Officer, and Principal Accounting Officer effective September 12, 2026. While the filing also discloses interim appointments of Janetta Trochimiuk and Frank Bedu-Addo to fill these roles, the principal disclosed action centers on the departure of the CFO. The resignation of a named executive officer in a financial leadership role is material to investors, though the interim appointments and lack of disagreement statement reduce the severity somewhat.
View raw filing on EDGAR →The filing discloses the resignation of Ms. Eva Yuk Yin Siu as executive director, Chairlady, and CEO effective August 18, 2026, and the resignation of Ms. Josephine Yan Yeung as independent director and committee chair. While the filing also announces appointments of Mr. Jiang as new Chairman/CEO and two other directors, the principal disclosed action is the departure of the CEO and board leadership, which is material to investors assessing management continuity and governance.
View raw filing on EDGAR →The report discloses the resignation of Mr. Shihua Li as a director and Audit Committee Chairperson, and Ms. Yee Hing Wan as Chief Financial Officer, both effective immediately on August 15, 2026. While the report also announces the appointment of replacements, the principal disclosed action is the departure of two officers, including the CFO. Both resignations are stated to be without disagreement or claims, but the simultaneous departure of the CFO and a key board member is material to investor assessment of governance and continuity.
View raw filing on EDGAR →The exhibit announces the departure of Chief Financial Officer Eyal Rubin, who "will be leaving the Company to pursue a new opportunity outside of the life science industry" effective September 18, 2026. Simultaneously, Oren Elmaliach, the Director of Finance, has been appointed Interim Chief Financial Officer. The primary disclosed action is Rubin's departure from a named executive officer role, making this an exec_departure event. The CFO transition at a clinical-stage pharmaceutical company is material to investors assessing management continuity and financial oversight.
View raw filing on EDGAR →Chris Polimeni resigned as Chief Financial Officer effective August 17, 2026, with no disagreement or cause noted. While Stephanie Brady was simultaneously appointed as Chief Accounting Officer and primary financial officer, the filing's primary focus and the Item 5.02 disclosure centers on Polimeni's departure from the CFO role. The appointment is secondary to the departure event.
View raw filing on EDGAR →Freddie Deutsch, Director of Specialty Business Lending and board member of both the Company and the Bank, is retiring effective January 15, 2027. The filing discloses his voluntary departure from his officer position and board seats, along with a Letter Amendment to his Employment Agreement governing the transition. While the disclosure also addresses compensatory arrangements (retention bonus, equity treatment, health coverage), the principal disclosed action is the executive's departure from his roles, making exec_departure the most salient classification.
View raw filing on EDGAR →Seven directors resigned from the Board of Internet Sciences Inc. between August 14–16, 2026, all effective immediately. The Item 5.02 disclosure centers on the departure of these board members (Michael Kahn, Dimitrius M. Hutcherson, Keith R. Wyche, Dr. Mark T. Maybury, James C. Forbes, Mark Deutsch, and Debra Bigman). None cited disagreement with the Company, though some cited time constraints or other board commitments. The near-simultaneous mass departure of a substantial portion of the board is material to investors' assessment of governance stability and continuity.
View raw filing on EDGAR →Mark A. Chiplock resigned as Executive Vice President, Chief Financial Officer and Chief Accounting Officer of Ameresco, Inc., effective September 25, 2026, to pursue other professional opportunities. The company has begun a search for a replacement and reaffirmed its financial guidance.
View raw filing on EDGAR →Zhak Cohen, a board nominee of GPC Fund under the Board Nominee Agreement, resigned from the Board effective August 17, 2026, in connection with his departure from Gallatin Point Capital LLC. This is a clear director departure disclosure under Item 5.02, with the principal action being a person leaving the board. The filing explicitly states no disagreement was involved, and the resignation was tied to his employment change at the fund manager.
View raw filing on EDGAR →David J. Corrsin, a long-tenured director and Executive Vice President and General Counsel since the company's 2000 formation, resigned from both his board seat and executive officer position effective August 17, 2026. While he transitions to a Special Legal Advisor role, the principal disclosed action is his departure from formal executive and directorial positions after 26 years of service, making this a material executive departure.
View raw filing on EDGAR →John Rogers, Chief Financial Officer of Smith & Nephew plc, has announced his resignation effective 30 September 2026 to take up an external position. The disclosure explicitly states he "informed the Board of his intention to leave his position as Chief Financial Officer" and "will step down from the Board with immediate effect." This is a clear executive departure of a named senior officer, material to investors assessing the company's leadership stability and financial oversight.
View raw filing on EDGAR →Peter C. Browning, a director since 2014 and former Lead Independent Director (February 2019 to January 2026), retired from the Board effective August 12, 2026. The filing explicitly discloses his departure under Item 5.02 and notes the Board size decreased to seven seats. While routine retirements can be administrative, the departure of a long-tenured director who previously held the Lead Independent Director role is material to investors' assessment of board composition and governance continuity.
View raw filing on EDGAR →Upon the effective time of the merger on August 17, 2026, all directors and officers of AvalonBay Communities ceased to hold their positions as AvalonBay ceased to exist and was merged into the surviving entity, with all executive roles replaced by those of the combined Vivmark Residential company.
View raw filing on EDGAR →Pete Suerken, President U.S. of Wendy's, notified the Company on August 14, 2026 of his intention to resign effective August 31, 2026 to become President and CEO of QSCC. While the filing also discloses compensatory arrangements (pro-rated vesting acceleration and cash incentive payment), the principal disclosed action is Suerken's departure from a senior executive role. The filing also notes elimination of the President, U.S. position and creation of a new Chief Operations Officer role, underscoring the significance of this departure.
View raw filing on EDGAR →Eric Foster, Chief Commercial Officer, notified the Company on August 11, 2026 of his resignation effective August 28, 2026. The disclosure centers on a named executive's departure from the Company. While disclosed under Item 8.01 (Other Events) rather than the typical Item 5.02, the substance is clearly an executive departure, and the CCO role is material to a commercial-stage biopharmaceutical company.
View raw filing on EDGAR →